Ayurveda Meets Equity: Shelter Pharma Rolls Out Convertible Cure

Image Source: Facebook

Shelter Pharma Ltd. recently announced a strategic capital raising of ₹384.6 million by way of issuance of convertible equity warrants. The move is to reinforce the financial pillar of the company and propel its growth in the Ayurvedic and herbal pharma segment. The warrants will be issued to promoters and non-promoters, reflecting widespread-based investor confidence in the growth of the company.

Fundraising Details

Amount to be Raised: ₹384.6 million
Instrument: Convertible equity warrants
Allottees: Promoters and non-promoters combination
Purpose: To finance business expansion, R&D, and working capital needs

About Shelter Pharma

Specialized company with experience in Ayurvedic and herbal formulations
Produces a wide range of products across human and animal health
Dedicated to natural, plant-based therapies with expanding domestic and export reach

Strategic Significance

Enhances capital structure and long-term financial flexibility
Signals promoter confidence and external investor interest
Enables expansion into new markets and product lines

What Are Convertible Warrants?

Financial instruments giving holders a right to convert to equity shares in the future
Typically issued at an agreed-upon price, aligning investor appetite with company performance
Delivers immediate injection of capital while delaying equity dilution

Sources: Moneycontrol, BSE India, Reuters